Acetyl hexapeptide-3 inhibits SNARE complex formation and catecholamine release, resulting in the reduction of the degree of existing facial wrinkles and demonstrated effectiveness against their development with regular use. In clinical studies of twice-a-day treatment, the severity of wrinkles around the eyes decreased up to 17% after 15 days and 27% following 30 days o f treatment.